BCAB
USDBioAtla Inc. Common Stock
$0.673+0.023 (3.615%)
即時價格
Healthcare
生物科技
美國
價格圖表
Loading Chart...
關鍵指標
市場指標
開盤
$0.650
最高
$0.678
最低
$0.613
交易量
0.11M
公司基本面
市值
39.5M
行業
生物科技
國家
United States
交易統計
平均交易量
1.01M
交易所
NCM
貨幣
USD
52週範圍
最低 $0.24當前 $0.673最高 $2.525
相關新聞
GlobeNewswire
BioAtla Presents Compelling Mechanistic Rationale for Targeting ROR2 with Ozuriftamab Vedotin (Oz-V) in Oropharyngeal Squamous Cell Carcinoma (OPSCC) at the Annual Conference of the International Papillomavirus Society
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the
查看更多
GlobeNewswire
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
SAN DIEGO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics using its
查看更多
